E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/18/2006 in the Prospect News Biotech Daily, Prospect News Convertibles Daily and Prospect News High Yield Daily.

Acusphere files $100 million shelf

By Jennifer Chiou

New York, May 18 - Acusphere, Inc. registered to sell up to $100 million of securities in an S-3 filing with the Securities and Exchange Commission.

Covered by the shelf are common stock, preferred stock, subordinated debt securities, senior debt securities and warrants. Preferred stock and securities may be structured as convertibles.

Proceeds will go towards general corporate purposes.

Based in Watertown, Mass., Acusphere is a pharmaceutical company focused on developing treatments for cancer, asthma and cardiac disorders.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.